Collaboration

Public Goods and Action Groups

To support the ongoing efforts of the Consortium for Cancer Implementation Science, a collection of public goods (widely available tools and resources) has been developed by the CCIS action groups to address key challenges and advance the implementation science agenda in cancer. If you are interested in getting involved with an action group, please contact us.

Contact Us

Active Action Groups

8 groups

Community Participation in Implementation Science

2020 - Present

The goal of this action group is to advance implementation science through identifying, elevating, and enhancing community-engaged research. Major goals include building competencies in research design and evaluation.

View Public Goods →

Environmental and Occupational Health in Implementation Science

This action group fosters transdisciplinary, multi-sectoral interactions and collaborations to address environmental and occupational health challenges using implementation science approaches.

Complex/Multi-level Contexts and Interventions

This action group explores the interface of complex/multilevel interventions and implementation science and creates tools to guide application in designing and evaluating such interventions.

View Public Goods →

Implementation Science in Global Health

2020 - Present

This action group focuses on implementation science research and practice for global cancer control through collaboration and capacity building to increase translation of evidence-based interventions in scalable, sustainable ways.

View Public Goods →

Learning Healthcare Systems as Natural Laboratories

This action group identifies opportunities and challenges to employing implementation science in learning healthcare system development and promotes research examining patient, clinician, and organizational factors driving uptake of interventions.

View Public Goods →

Implementation and Technology

This action group aims to identify effective, evidence-based technologies and understand best practices, barriers, and facilitators of their adoption with a focus on digital health supporting guideline-concordant cancer care.

View Public Goods →

Contextual Drivers of Implementation in Cancer Control

Description pending — to be provided with Round 2 feedback.

Population Health Strategies in Implementation Science

Description pending — to be provided with Round 2 feedback. Note: this action group may be renamed.

Inactive / Archived Groups

These action groups have completed their primary objectives or are currently on hiatus. Some have produced valuable public goods that remain available.

Economics and Cost in Implementation Science

2019 - 2020

This action group worked to understand implementation costs, cost bearers, and distinguish between intervention versus implementation expenses.

View Public Goods →

Implementation Science Study Designs

2019 - 2022

This action group worked to identify optimal research methods and study designs that accommodate rapid changes in context and responsive intervention adaptations.

Precision Health and Big Data in Implementation Science

2019 - 2020

This action group worked to guide precision health activities across the cancer continuum, build training capacity, establish networks for measures/tools, and conduct pragmatic learning healthcare studies.

Rapid Cycle Design in Implementation Science

2019 - 2020

This action group developed guidance for advancing methodology related to rapid cycle designs.

View Public Goods →

Note

This work is supported (or partially supported) by the Consortium for Cancer Implementation Science (CCIS) Public Good Awards.

  • * Cycle 1 Funding – October 2021
  • ** Cycle 2 Funding – April 2022
  • *** Cycle 3 Funding – March 2023

This work is responsive to priorities identified by action group members in:

  • § 2019
  • §§ 2020
  • §§§ 2021
  • §§§§ 2022
  • §§§§§ 2023

This website is supported by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) as part of a financial assistance award. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by NCI/NIH, or the U.S. Government. [Placeholder — final acknowledgment text to be supplied by CCIS team.]